 |
| ----------------------------------------------------------------------------------------- |
7.00-7.30 am Registration and continental breakfast |
7.30-9.30 am SESSION - I |
| Multidisciplinary management of upper GI malignancies |
| Moderators: |
Keith Naunheim, MD and Paul Schultz, MD |
| Oncologist: |
John McDonald, MD |
| Radiation Oncologist: |
Joel Tepper, MD |
| Esophageal Surgeon: |
Thomas Rice, MD |
| Gastroenterologist: |
Stuart Spechler, MD |
| Gastric Surgeon: |
Paul Mansfield, MD |
| Pathologist: |
John Hart, MD |
| |
|
| Points of discussion: |
 |
Staging evaluation of patients with esophageal and gastric cancer |
|
Treatment of intramucosal esophageal and gastric cancer |
| |
 |
Role of Endoscopic therapy |
|
|
Role of chemo-radiation |
| |
|
Pre-op vs post-op XRT |
|
Role for definitive chemoradiation |
|
|
Surgery for esophageal and gastric cancer |
| |
|
Description of various surgical procedures performed |
|
How to chose a surgical procedure in any given patient |
|
|
Esophageal stents vs PEG for nutritional support and palliation |
|
Follow-up care |
| |
|
Evaluation for recurrent tumor |
|
Management of patients with recurrent tumor |
|
|
Back
----------------------------------------------------------------------------------------- |
9.30-9.45 am Coffee Break |
9.45-11.45 am SESSION - II |
| Endoscopic Ultrasound: God’s gift to mankind or much ado about nothing |
| Moderators: |
Banke Agarwal, MD and Edward Lin, MD |
| Luminal cancers (esophageal/gastric/rectal): |
Paul Fockens, MD, PhD |
| Pancreatic cancers: |
Kenneth Chang, MD |
| Neuroendocrine tumors: |
Richard Erickson, MD |
| Lung cancer: |
Mohamad Eloubeidi, MD, MHS |
| EUS-guided therapy: |
Michael Levy, MD |
| Screening for pancreatic cancert: |
Marcia Canto, MD |
| |
|
| Points of discussion: |
|
Role of EUS in staging of GI and lung cancers |
|
Potential impact of EUS in early diagnosis of pancreatic cancer |
|
State of the art on screening for pancreatic cancer in high risk individuals |
|
EUS in evaluation and management of patients with suspected neuroendocrine tumors. |
|
Potential role of EUS-FNA for tumor ablation |
|
EUS-guided therapy for palliation of unresectable cancer |
|
Back
----------------------------------------------------------------------------------------- |
11.45-12.45 pm Lunch |
| 12-45-2.45 pm SESSION - III |
| Management of pancreatobiliary neoplasms |
| Moderators: |
Steven Edmundowicz, MD and David Linehan, MD |
| |
|
| Surgical principles of management of pancreatobiliary carcinoma |
| 12.45-1.15 pm Pancreatic Cancer: |
Steven Strasberg, MD |
| |
|
|
Description of surgical procedures for management of pancreatic cancer |
|
Pre-operative work-up prior to surgery |
|
Choosing patients for surgery |
| |
|
Patient factors |
|
Tumor factors |
|
|
Patients with borderline resectable pancreatic cancer |
| |
|
Role of pre-operative chemoradiation for downstaging |
|
|
Expected outcomes after surgical resection |
| |
|
After R0 resection |
|
After R1 or R2 resection |
|
|
Follow-up of patients after surgical resection |
| |
|
| 1.15-1.45 pm Cholangiocarcinoma: William Jarnagin, MD |
| |
|
|
Description of surgical procedures for management of cholangiocarcinoma |
| |
|
Intrahepatic cholangiocarcinoma |
|
Extrahepatic cholangiocarcinoma |
|
|
Pre-operative work-up prior to surgery |
|
Choosing patients for surgery |
| |
|
Patient factors |
|
Tumor factors |
|
|
Role of chemo-radiation/liver transplant |
|
Expected outcomes after |
| |
|
R0 resection |
|
R1 or R2 resection |
|
|
Follow-up/management of patients after surgical resection |
| |
|
| 1.45-2.45 pm |
Management of Mucinous Cystic neoplasms |
| Surgeon: |
Jeffrey Matthews, MD |
| Endosonographer: |
William Brugge, MD |
| Pathologist/cytologist: |
Greg Staerkel, MD |
| |
|
| Points of discussion: |
|
Pre-operative identification of mucinous cystic neoplasms with EUS-FNA |
|
Role of cytology in identification and characterization of mucinous cyst lesions. |
|
Rationale for treatment of mucinous cystic neoplasms |
|
How to determine which lesion requires treatment |
| |
|
Morphologic characteristics of lesion |
|
Cytologic characteristics of EUS-FNA specimen |
|
Biochemical analysis of cyst aspirate |
|
Location of the cyst |
|
Patient factors |
|
|
Surgical and non-surgical approaches to treatment of mucinous cystic neoplasms |
| |
|
Patient selection |
|
Outcomes |
|
|
Back
----------------------------------------------------------------------------------------- |
| 2.45-3.00 pm Coffee Break |
| 3.00-5.00 pm SESSION - IV |
| Improving diagnosis of GI cancer with advances in endoscopic technology |
| Moderators: |
Giuseppe Aliperti, MD and Timothy Brady, MD |
| |
|
| 3.00-3.45 pm |
Determination of etiology of biliary strictures after brush cytology is negative for malignancy |
| Cholangioscopy: |
Bret Petersen, MD |
| EUS-FNA/IDUS: |
John DeWitt, MD |
| |
|
| 3.45-4.15 pm State of the art lecture: |
Newer endoscopic techniques for colon cancer screening |
| |
Jacques Van Dam, MD, PhD |
| |
|
| 4.15-5.00 pm |
Imaging of small bowel |
| Capsule Endoscopy: |
Lauren Gerson, MD |
| Double Balloon Enteroscopy: |
Oleh Haluzka, MD |
|
Back
----------------------------------------------------------------------------------------- |
| 5.00 pm Conference Adjourned |
Session I
